The DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index.
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Open accessAbstract
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinsonism, is now recognised as a range of motor and behavioural syndromes that are associated with a characteristic 4-repeat tau neuropathology. New research criteria that recognise early presentations of PSP and operationalise diagnosis of the full spectrum of clinical phenotypes have been reported. The Movement Disorders Society PSP diagnostic criteria include syndromes with few or mild symptoms that are suggestive of underlying PSP pathology and could provide an opportunity for earlier therapeutic interventions in the future. These criteria also include definitions for variant PSP syndromes with different patterns of movement, language, or behavioural features than have been conclusively associated with PSP pathology. Data from new diagnostic biomarkers can be combined with the clinical features of disease to increase the specificity of the new criteria for underlying PSP pathology. Because PSP is associated with tau protein abnormalities, there is growing interest in clinical trials of new tau-directed therapies. These therapies are hypothesised to have disease-modifying effects by reducing the concentration of toxic forms of tau in the brain or by compensating for loss of tau function. Since tau pathology is also central to Alzheimer's disease and chronic traumatic encephalopathy, a successful tau therapeutic for PSP might inform treatment of other neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although the presence of an overt frontotemporal dementia syndrome can be defined on the basis of established criteria, there are no such criteria for the prodromal forms of fronto temporal lobar degeneration, except for progressive supranuclear See Online for appendix Review palsy.31”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [31]
In the citing paper
“Neuropathologically, PSP is defined by the accumulation of pTau in both neurons and glial cells.369”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [369]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Classification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Appelhof, B., Bakker, C., den IJssel, J. C. L. V. D., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,774
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Self-citationClinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., Mollenhauer, B., Müller, U., Nilsson, C., Whitwell, J. L., et al. (2017) · Movement Disorders · doi:10.1002/mds.26987 · Cited by 2,434
Self-citationQualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., Swieten, J. C. V., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,065
Progressive Supranuclear Palsy
Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904
Self-citationDepletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
MDS research criteria for prodromal Parkinson's disease
Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G. M., Joseph, L., et al. (2015) · Movement Disorders · doi:10.1002/mds.26431 · Cited by 1,394
Self-citation
Cited by
Sorted by citations
Items 301–400 of 486
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.001 · Cited by 3
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.002 · Cited by 3
Ono, Y., Higashida, K., Yoshikura, N., Hayashi, Y., Kimura, A., Iwasaki, Y., Yoshida, M., & Shimohata, T. (2022) · Neuropathology · doi:10.1111/neup.12805 · Cited by 3
Probable progressive supranuclear palsy in a patient with chronic schizophrenia: A case report
Kita, A., Tsuji, T., Koh, J., Takahashi, S., Yamamoto, M., Sakamoto, Y., Itogawa, H., & Kimoto, S. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11411 · Cited by 3
Top 100 most-cited articles on tau protein: a bibliometric analysis and evidence mapping
Chen, Z., Shan, G., Wang, X., Zuo, Y., Song, X., Ma, Y., Zhao, X., & Jin, Y. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1345225 · Cited by 3
Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series
Ichijo, K., Takahata, K., Kurose, S., Watanabe, T., Nagase, Y., Endo, H., Tagai, K., Ishitobi, M., & Higuchi, M. (2024) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.178 · Cited by 3
Altimus, C. M., Keller, K. E., Brannelly, P., Ross, E., Lin, C.-Y., Riley, E. A. U., Briggs, L., Smith, J. P., & Stevens, M. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.07.218 · Cited by 3
Stratégie diagnostique devant des troubles cognitifs majeurs du sujet jeune
Wallon, D. (2019) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2019.02.001 · Cited by 3
García‐González, P., Lara, H. R., Compta, Y., Fernandez, M., van der Lee, S. J., de Rojas, I., Saiz-Aúz, L., Painous, C., Camara, A., Muñoz, E., et al. (2024) · medRxiv · doi:10.1101/2024.06.21.24309279 · Cited by 3
MAPT Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes
Gagliardi, M., Procopio, R., Felicetti, A., Annesi, G., Talarico, M., Vescio, B., Quattrone, A., & Quattrone, A. (2025) · Biomedicines · doi:10.3390/biomedicines13061405 · Cited by 3
Progressive Supranuclear Palsy and Corticobasal Syndrome
McFarland, N. R. (2025) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001607 · Cited by 2
Lin, H.-C., Huang, K., Chen, S.-H., Ho, T., Huang, C.-C., Hsu, J., Chang, C., Lin, K., & Hsiao, I. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07539-x · Cited by 2
Wang, B., Wang, H., Kang, Y., Wu, S., Jin, N., Wang, H., Cen, Z., Yang, D., Chen, X., Dou, X., et al. (2025) · Movement Disorders · doi:10.1002/mds.70099 · Cited by 2
18F-FDG, 18F-FP-CIT, and 18F-Florzolotau PET Imaging in Progressive Supranuclear Palsy
Liang, M., Jia, C., Huang, Z., Zhang, T., Li, Q., Wu, M., Yen, T., Wang, H., & Cui, R. (2025) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000006254 · Cited by 2
Dai, M., Lin, Y., Gan, R., Shen, X., Park, S. Y., Lee, S., & Su, Q. (2026) · Microbiota Medicine Research · doi:10.1002/mmr3.70004 · Cited by 1
Kukkle, P. L., Garg, D., Ganguly, J., Desai, S., Kandadai, R. M., Mehta, S., Wadia, P. M., Joshi, D., Sahoo, L. K., Paramanandam, V., et al. (2026) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70672 · Cited by 2
Gene-Environment Interactions in Progressive Supranuclear Palsy
Litvan, I., Proudfoot, J. A., Martin, E. R., Standaert, D. G., Riley, D. E., Hall, D. A., Marras, C., Bayram, E., Dubinsky, R., Bordelon, Y. M., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.664796 · Cited by 2
Self-citationStrategy Adherence: A Specific and Rapidly Progressive Deficit in Progressive Supranuclear Palsy
Brzezicki, M. A., Bogdanovic, M., Buchanan, T. J., FitzGerald, J. J., & Antoniades, C. A. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13334 · Cited by 2
Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00009-3 · Cited by 2
Andriuta, D., Wiener, E., Perron, A., Ouin, E., Masmoudi, I., Thibaut, W., Martin, J. E., Roussel, M., Constans, J., Aarabi, A., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-12009-1 · Cited by 2
Cheong, I., Du, Y., Smith, G. S., Hua, J., Li, X., & Pantelyat, A. Y. (2023) · Neurodegenerative Diseases · doi:10.1159/000536614 · Cited by 2
Maiuolo, M. L., Giorgini, R., Vaccaro, M. G., Facchin, A., Quattrone, A., & Quattrone, A. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1438830 · Cited by 4
Abate, F., Biasio, F. D., Marchese, R., Markushi, T. B., Ciammola, A., Ticozzi, N., Buonaura, G. C., Cani, I., Sambati, L., Fabbrini, G., et al. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107226 · Cited by 2
Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET/CT system
Yang, X., Wu, M., Liang, M., Zhang, H., Li, B., Mao, C., Dong, L., Wang, Y., Xing, H., Ren, C., et al. (2024) · EJNMMI Physics · doi:10.1186/s40658-024-00712-5 · Cited by 2
Picillo, M., Abate, F., Canoro, V., Tepedino, M. F., Barone, P., & Erro, R. (2025) · Neurological Sciences · doi:10.1007/s10072-025-07996-0 · Cited by 2
Taste impairment in patients with Parkinsonism
Zhu, Q., Liu, H., Wang, J., Feng, R., Ma, M., Wang, X., & Ding, X. (2025) · Journal of Neurology · doi:10.1007/s00415-025-12983-8 · Cited by 2
Isroff, C. E., Kang, K., Espay, A. J., Dale, M. L., Pantelyat, A. Y., Wills, A.-M. A., & Antoniades, C. A. (2025) · Brain Sciences · doi:10.3390/brainsci15060587 · Cited by 2
Braun, A. S., Satoh, R., Pham, N. T. T., Singh, N. A., Ali, F., Dickson, D. W., Lowe, V. J., Whitwell, J. L., & Josephs, K. A. (2025) · Annals of Neurology · doi:10.1002/ana.27265 · Cited by 2
Chronic traumatic encephalopathy: an update review
Reuck, J. D. (2021) · Journal of Neurology & Stroke · doi:10.15406/jnsk.2021.11.00476 · Cited by 1
An Unusual Presentation of Progressive Supranuclear Palsy
Dec‐Ćwiek, M., Boczarska‐Jedynak, M., & Pera, J. (2021) · Neurology India · doi:10.4103/0028-3886.333499 · Cited by 2
Translational Neurology of Slow Saccades
Rucker, J. C., Hudson, T. E., & Rizzo, J. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-31407-1_12 · Cited by 2
Tönges, L., Bartig, D., Muhlack, S., Jost, W. H., Gold, R., & Krogias, C. (2019) · Der Nervenarzt · Cited by 2
Neuroprotektive Therapien bei Tauopathien
Respondek, G., Krey, L., Huber, M. K., Pflugrad, H., Wegner, F., & Höglinger, G. U. (2021) · Der Nervenarzt · doi:10.1007/s00115-021-01210-0 · Cited by 3
Self-citationTranscranial direct current stimulation as a therapeutic opportunity in PSP
Vanacore, N., & Canevelli, M. (2019) · Neurology · doi:10.1212/wnl.0000000000007889 · Cited by 2
Diagnosing Subtypes of Progressive Supranuclear Palsy
Desai, I., & Kumar, N. (2022) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_703_22 · Cited by 1
Differenzialdiagnose von Liderkrankungen in der Neuroophthalmologie
Steffen, H. (2023) · Springer eBooks · doi:10.1007/978-3-662-64261-0_25 · Cited by 1
Papamichail, P., Michalas, M., Krokos, D., Balamoutsou, M., Karkoula, P., Lyros, E., Sakellari, V., & Christakou, Α. (2024) · Applied Sciences · doi:10.3390/app14188368 · Cited by 1
Germani, M., Mesa, I. R., Buchanan, T. J., Bruyn, S. D., Gasalla, T., Tricht, H. L. G. V., Ewen, C., Golbe, L. I., Boxer, A. L., & Höglinger, G. U. (2024) · Movement Disorders · doi:10.1002/mds.30027 · Cited by 1
Self-citationDurcan, R., Paula, H., Ghosh, B. C. P., Street, D., High, J., McAlister, C., Shepstone, L., Russell, C., Grant, K., Igosheva, N., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-099577 · Cited by 1
Verbal fluency is associated with Gait impairment in Progressive Supranuclear Palsy
D’Souza, A., Sotirakis, C., Conway, N., FitzGerald, J. J., & Antoniades, C. A. (2025) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2025.100380 · Cited by 1
Conring, A. L., Ye, L., Wegner, F., Körner, S., Hegelmaier, T., Höllerhage, M., & Klietz, M. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-03032-9 · Cited by 1
Multiple system atrophy presenting as oromandibular dystonia and bruxism
Thomas, D. C., Pitchumani, P. K., Singer, S. R., Selvaraj, B., & Prabhakar, V. (2025) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2025.07.023 · Cited by 1
Kim, R., Kim, H. J., Lee, S., Jin, B., Kim, S., Ha, S. H., Choi, S., Shin, J. H., Kim, H.-J., Jeon, B., et al. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-03091-y · Cited by 1
Li, E., Song, F., Coppola, Q., Yack, L. M., Le, M. M., Javed, S., Pandher, N., Prufer, I., Mayzel, O., Heuer, H. W., et al. (2026) · Trials · doi:10.1186/s13063-025-09382-9 · Cited by 1
Self-citationYao, J., Ma, J., Li, P., Liao, X., Zan, J., Hu, L., & Li, G. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1727812 · Cited by 1
Dementia in Progressive Supranuclear Palsy: A Narrative Review
Moore, K. S., Stipho, Y. S., Niemann, N., Shill, H. A., Chan, J., Abrego, C. J., Eagan, D. E., Decourt, B., & Sabbagh, M. N. (2026) · Neurology and Therapy · doi:10.1007/s40120-025-00884-x · Cited by 1
Short tandem repeat expansions in patients with neurodegenerative dementia
Zhu, Y., Xiao, X.-W., Liu, Y.-L., Wang, Z., Luo, T., Xu, T.-Y., Yang, Q.-J., Hao, X.-L., Zhang, C., Zhang, S.-Z., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106190 · Cited by 1
Jang, K.-B., Kang, D., Lee, M.-H., Lukianenko, N., Kim, Y. K., Lim, S., Kim, S., & Cho, H. J. (2026) · Scientific Reports · doi:10.1038/s41598-026-42195-7 · Cited by 1
Tau conformation, distribution and PET imaging correlations in progressive supranuclear palsy
Dong, C., Ma, J., Qiao, H., Tamagnan, G. D., Chan, P., & Liu, S. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00545-5 · Cited by 2
Clinicopathological features of primary tauopathies: a brain bank series
Ryan, B., Marriott, L., Murray, H. C., Faull, R. L. M., Turner, C. P., & Curtis, M. A. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1768959 · Cited by 1
Fulco, E. (2026) · Cureus · doi:10.7759/cureus.109779 · Cited by 1
Revising a diagnosis of functional neurological disorder—a case report
Berry, A. J., & Wiethoff, S. (2020) · Oxford Medical Case Reports · doi:10.1093/omcr/omaa073 · Cited by 1
Molecular Imaging of Neurodegenerative Parkinsonism
Frey, K. A., & Bohnen, N. I. (2021) · PET Clinics · doi:10.1016/j.cpet.2020.12.002 · Cited by 1
Dalmau, J. O., & Graus, F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108696722.016 · Cited by 1
MAPT gene mutation in familiar progressive supranuclear palsy, a case report
Rodríguez-López, J., Kreinter, H., Pérez, N. M. Z., Garay, Ó. A. O., & Jiménez, C. (2022) · Neurology Perspectives · doi:10.1016/j.neurop.2022.05.001 · Cited by 1
The current state of pharmacotherapy for extrapyramidal diseases
Menšíková, K., Nevrlý, M., Hvizdošová, L., Kaiserová, M., Kurčová, S., Vaštík, M., Bardoň, J., Bartoníková, T., Grambalova, Z., Grambal, A., et al. (2021) · Neurologie pro praxi · doi:10.36290/neu.2021.034 · Cited by 1
Criterios diagnósticos en la enfermedad demencial ¿Qué hay de nuevo?
Labos, E., Bavec, C. V., Cristalli, D. O., Deschle, F., Isaac, C. F., Dorman, G. S., Ollari, J., Rubiño, V., & Russo, M. J. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i160.460 · Cited by 4
Persely, A., Beszedics, B., Pálóczi, K., Piroska, M., Alijanpourotaghsara, A., Strelnikov, D., Vessal, A., Szabó, H., Hernyes, A., Zoldi, L., et al. (2023) · Medicina · doi:10.3390/medicina59101696 · Cited by 1
Asbeutah, S., Ponomareva, G., Molla, M., & Shah, S. (2023) · Cureus · doi:10.7759/cureus.47313 · Cited by 1
López, A. G., López‐Muñoz, S., Caballero, G., de Anta, N. C., Rojo, L., Vidal‐Robau, N., Muñoz, A., Ortiz, E., Archilla, I., Díaz, S., et al. (2024) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-024-03781-0 · Cited by 1
Progressive supranuclear palsy
Balekundri, A., Ahire, E. D., Surana, K. R., & Keservani, R. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00022-x · Cited by 1
Akiyama, N., Kanazawa, M., Kasuga, K., Hatakeyama, M., Ikeuchi, T., & Onodera, O. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14313 · Cited by 1
Kawabata, K., Banno, F., Mizutani, Y., Maeda, T., Nagao, R., Shima, S., Murayama, K., Ohno, Y., Maeda, T., Sasaki, M., et al. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107251 · Cited by 1
Corticobasal Degeneration and Corticobasal Syndrome
Saranza, G., Armstrong, M. J., & Lang, A. E. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108989855.034 · Cited by 1
Self-citationScotton, W. J., Shand, C., Todd, E. G., Bocchetta, M., Kobylecki, C., Cash, D. M., VandeVrede, L. A., Heuer, H. W., Quaegebeur, A., Young, A. L., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf066 · Cited by 3
Self-citationDeep brain stimulation in progressive supranuclear palsy: a dead-end story? A narrative review
Bellini, G., Rauso, G. D., Fontanelli, L., Benevento, E., Becattini, L., Frosini, D., Ceravolo, R., & Prete, E. D. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02904-4 · Cited by 1
Tau in Tauopathies That Leads to Cognitive Disorders and in Cancer
Huda, M. N., & Pan, C. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.74025 · Cited by 1
[18F]FDG-PET/CT in Movement Disorders
Fazio, P., & Varrone, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-01523-7_6 · Cited by 1
Treatment of Progressive Supranuclear Palsy
Xing, Y., & Litvan, I. (2019) · Current clinical neurology · doi:10.1007/978-3-319-97897-0_32 · Cited by 1
Self-citationCummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.004 · Cited by 1
Neuroimaging in multiple system atrophy
Tondo, G., Comi, C., Naldi, A., de Natale, E. R., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00008-7 · Cited by 1
The role of magnetic resonance imaging in the diff erential diagnosis of Parkinson’s disease
Tappakhov, A. A., & Popova, T. E. (2023) · Russian neurological Journal · doi:10.30629/26587947-2023-28-1-5-12 · Cited by 1
Novel Therapeutic Targets and Biomarkers for the Treatment of Progressive Supranuclear PalsyPreprint
Tyer, I., & Hill, A. (2020) · Preprints.org · doi:10.20944/preprints202006.0147.v1 · Cited by 1
A Systematic Review and Meta-Analysis of Deep Brain Stimulation for Progressive Supranuclear PalsyPreprint
Wen, Y., Jiao, B., Zhou, Y., & Shen, L. H. (2020) · Research Square · doi:10.21203/rs.3.rs-122655/v1 · Cited by 1
Feasibility of Short Imaging Protocols for [18F]PI-2620 Tau-PET in Progressive Supranuclear PalsyPreprint
Song, M., Scheifele, M., Barthel, H., van Eimeren, T., Beyer, L., MAREK, K. L., Eckenweber, F., Palleis, C., Kaiser, L., Finze, A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-180630/v1 · Cited by 1
Self-citationAssessment and staging of A/T/N with a single dynamic [ 18 F]PI-2620 recordingPreprint
Gnörich, J. S., Kusche‐Palenga, J., Kling, A., Dehsarvi, A., Bronte, A., Frontzkowski, L. K., Zatcepin, A., Zaganjori, M., Schöberl, F., Roemer, S. N., et al. (2025) · medRxiv · doi:10.1101/2025.01.14.25320240 · Cited by 1
Self-citationBiomarkers for atypical Parkinsonism: Some progress, but much work remains
Feigin, A., & Siderowf, A. D. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.025
Aktuelle Therapiestudien im Bereich der atypischen Parkinson Syndrome
Schweyer, K., Levin, J., & Höglinger, G. U. (2018) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-0586-3440
Self-citationFrontotemporale Demenz: Welche Klassifikation ist sinnvoll?
Kukolja, J. (2018) · NeuroTransmitter · doi:10.1007/s15016-018-6475-9
The postsynaptic protein neurogranin: a new item in the Alzheimer’s disease biomarker toolbox
Kvartsberg, H. (2019) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Uncovering the Secret Hidden Beneath a Failing Memory
Menon, P. V., Feng, T. L., & Seetharaman, S. K. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.04.014
Störungen der Basalganglienfunktion
Franke, C., & Storch, A. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-21882-8.00008-6
Miller‐Patterson, C., Krobot, K. E., Burton, E. A., & Smith, L. J. (2020) · Springer eBooks · doi:10.1007/978-3-030-28852-5_13
Progressive Supranuclear Palsy
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.007
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.005 · Cited by 1
Westgotenzeitiche Kapitelle im Duero-Gebiet und in Asturiem: "mit 2 Textabbiidungen und Tafel 78-82"
Noack-Haley, S. (1986) · Madrider Mitteilungen
Parálisis supranuclear progresiva
Sánchez‐Ferro, Á., & Suárez, P. R. (2021) · Kranion · doi:10.24875/kranion.m21000006
Abnormal Movements in Neurological Autoimmune Disorders
Dalmau, J. O., & Graus, F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108696722.022
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.006
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.012
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.008
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.011
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.003
Doll, E. J., & Ruel, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-28852-5_32
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.015
(2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000521
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.013
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.010
Asymmetrisches Parkinson-Syndrom, posturale Instabilität und subtile Augenbewegungsstörung
Kwon, E. H. (2022) · Springer eBooks · doi:10.1007/978-3-662-63309-0_4
Cummings, L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108587921.014
Metadata
- Authors
- Boxer, A. L., Yu, J.-T., Golbe, L. I., Litvan, I., Lang, A. E., & Höglinger, G. U.
- Affiliations
- University of California, San Francisco (US)
- Qingdao University (CN)
- Rutgers, The State University of New Jersey (US)
- University of California San Diego (US)
- University of Toronto (CA)
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Boxer, Adam L
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 16
- Issue
- 7
- Pages
- 552-563
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC5802400
- OpenAlex
- W2625168757
- Cited by
- 485
- References
- 105
- Citations by year
- 2026: 45 · 2025: 52 · 2024: 59 · 2023: 42 · 2022: 57 · 2021: 56 · 2020: 62 · 2019: 61 · 2018: 43 · 2017: 7
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (HO2402/6‐2)
- National Institutes of Health
- National Institute on Aging (P50AG005131, U01AG045390, R01AG038791, P01AG019724)
- National Heart, Lung, and Blood Institute (T35HL007491)
- National Institute of Neurological Disorders and Stroke (U01NS086659, U54NS092089)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- progressive supranuclear palsy, diagnostic criteria, tau pathology, 4-repeat tau, biomarkers, atypical parkinsonism, disease-modifying therapy, neurodegenerative diseases, Alzheimer's disease, chronic traumatic encephalopathy
- MeSH terms
- Humans, Supranuclear Palsy, Progressive, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
